| | Patients population () |
| | Age (yy) | 65,97 ± 10,74 | | Sex (M : F) | 85 : 60 | | BMI (kg/m2) | 23,94 ± 4,08 | | ASA score | | | 1 | 18 (12,4%) | | 2 | 83 (57,2%) | | 3 | 41 (28,3%) | | 4 | 3 (2,1%) | | Diabetes | 32 (22,1%) | | Preoperative biliary stenting | 76 (52,4%) | | Albumin (g/dL) | 4,12 ± 0,37 | | Cholinesterase (kUI/L) | 8,41 ± 2,31 | | Total blood protein (g/L) | 68,65 ± 6,15 | | Hemoglobin (g/dL) | 12,99 ± 1,60 | | Hematocrit (%) | 38,29 ± 4,56 | | Neoadjuvant CT-RT | 12 (8,30%) | | Intraoperative blood loss (mL) | 373,10 ± 265,75 | | Surgery time (min) | 468,91 ± 68,61 | | Blood transfusion | 26 (18%) | | Pylorus preserving PD | 128 (88,2%) | | LOS (days, median, and range) | 12 (3–108) | | Overall morbidity | 89 (59,3%) | | Mortality | 6 (4,1%) | | Clavien | | | 0 | 59 (40,70%) | | I | 6 (4,1%) | | II | 48 (33,1%) | | IIIa | 16 (11,0%) | | IIIb | 7 (4,8%) | | IV | 3 (2,10%) | | V | 6 (4,10%) | | POPF | 41 (28,3%) | | Grade A | 18 (12,4%) | | Grade B | 16 (11,0%) | | Grade C | 7 (4,8%) | | Biliary fistula | 10 (6,90%) | | Lymphatic fistula | 9 (6,20%) | | Postoperative bleeding | 19 (13,10%) | | Delayed gastric empting | 4 (2,8%) | | Reintervention | 9 (6,20%) | | Readmission | 9 (6,20%) |
|
|
